Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 3
1955 1
1959 1
1960 1
1961 1
1962 5
1963 5
1964 3
1965 7
1966 14
1967 7
1968 13
1969 11
1970 11
1971 6
1972 9
1973 6
1974 10
1975 3
1977 6
1978 12
1979 4
1980 12
1981 9
1982 6
1983 14
1984 11
1985 19
1986 18
1987 24
1988 21
1989 13
1990 10
1991 22
1992 24
1993 23
1994 22
1995 35
1996 27
1997 28
1998 28
1999 40
2000 29
2001 45
2002 37
2003 41
2004 28
2005 40
2006 41
2007 47
2008 45
2009 44
2010 50
2011 53
2012 51
2013 55
2014 84
2015 65
2016 87
2017 64
2018 80
2019 78
2020 79
2021 93
2022 57
2023 59
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

1,763 results

Results by year

Filters applied: . Clear all
Page 1
Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer.
Yachida S, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, Watanabe H, Masuda K, Nishimoto Y, Kubo M, Hosoda F, Rokutan H, Matsumoto M, Takamaru H, Yamada M, Matsuda T, Iwasaki M, Yamaji T, Yachida T, Soga T, Kurokawa K, Toyoda A, Ogura Y, Hayashi T, Hatakeyama M, Nakagama H, Saito Y, Fukuda S, Shibata T, Yamada T. Yachida S, et al. Among authors: ogura y. Nat Med. 2019 Jun;25(6):968-976. doi: 10.1038/s41591-019-0458-7. Epub 2019 Jun 6. Nat Med. 2019. PMID: 31171880
Efficacy and safety of the sodium-glucose co-transporter-2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double-blind, placebo-controlled, 52-week clinical trial (EMPA-ELDERLY).
Yabe D, Shiki K, Homma G, Meinicke T, Ogura Y, Seino Y; EMPA-ELDERLY Investigators. Yabe D, et al. Among authors: ogura y. Diabetes Obes Metab. 2023 Dec;25(12):3538-3548. doi: 10.1111/dom.15249. Epub 2023 Aug 25. Diabetes Obes Metab. 2023. PMID: 37622398 Clinical Trial.
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration.
Dugel PU, Koh A, Ogura Y, Jaffe GJ, Schmidt-Erfurth U, Brown DM, Gomes AV, Warburton J, Weichselberger A, Holz FG; HAWK and HARRIER Study Investigators. Dugel PU, et al. Among authors: ogura y. Ophthalmology. 2020 Jan;127(1):72-84. doi: 10.1016/j.ophtha.2019.04.017. Epub 2019 Apr 12. Ophthalmology. 2020. PMID: 30986442 Free article. Clinical Trial.
Reply.
Dugel PU, Koh A, Ogura Y, Jaffe GJ, Schmidt-Erfurth U, Brown DM, Gomes AV, Warburton J, Weichselberger A, Holz FG; HAWK and HARRIER Study Investigators. Dugel PU, et al. Among authors: ogura y. Ophthalmology. 2019 Dec;126(12):e96-e97. doi: 10.1016/j.ophtha.2019.08.016. Ophthalmology. 2019. PMID: 31759510 No abstract available.
Polypoidal Choroidal Vasculopathy: Consensus Nomenclature and Non-Indocyanine Green Angiograph Diagnostic Criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup.
Cheung CMG, Lai TYY, Teo K, Ruamviboonsuk P, Chen SJ, Kim JE, Gomi F, Koh AH, Kokame G, Jordan-Yu JM, Corvi F, Invernizzi A, Ogura Y, Tan C, Mitchell P, Gupta V, Chhablani J, Chakravarthy U, Sadda SR, Wong TY, Staurenghi G, Lee WK. Cheung CMG, et al. Among authors: ogura y. Ophthalmology. 2021 Mar;128(3):443-452. doi: 10.1016/j.ophtha.2020.08.006. Epub 2020 Aug 11. Ophthalmology. 2021. PMID: 32795496 Free article.
1,763 results